First Time Loading...

Arbutus Biopharma Corp
NASDAQ:ABUS

Watchlist Manager
Arbutus Biopharma Corp Logo
Arbutus Biopharma Corp
NASDAQ:ABUS
Watchlist
Price: 3.36 USD 1.2% Market Closed
Updated: Jun 1, 2024
ABUS
/
Balance Sheet
/
Total Current Assets

Arbutus Biopharma Corp
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arbutus Biopharma Corp
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Arbutus Biopharma Corp
NASDAQ:ABUS
Total Current Assets
$135.9m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
0%
Abbvie Inc
NYSE:ABBV
Total Current Assets
$38.9B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$14B
CAGR 3-Years
2%
CAGR 5-Years
-16%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$28B
CAGR 3-Years
10%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$13.3B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$18.9B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Arbutus Biopharma Corp's Total Current Assets?
Total Current Assets
135.9m USD

Based on the financial report for Mar 31, 2024, Arbutus Biopharma Corp's Total Current Assets amounts to 135.9m USD.

What is Arbutus Biopharma Corp's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
0%

Over the last year, the Total Current Assets growth was -11%.

ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.